2021-01-28 08:24:19 LBAI Lakeland Bancorp
01/28/21 01/2808:24 01/28/2108:24 | Lakeland Bancorp reports Q4 EPS 37c, consensus 29cAt December 31, 2020, stockholders' equity was $763.8 million compared to $725.3 million at December 31, 2019, a 5% increase. Lakeland Bancorp remains above FDIC "well capitalized" standards, with a Tier 1 leverage ratio of 8.37% at December 31, 2020. At December 31, 2020, the book value per common share increased 5% to $15.13 and tangible book value per common share increased 7% to $11.97. Thomas Shara, Lakeland Bancorp's President and CEO commented, "2020 turned out to be a year that no one could have anticipated. We have all been directly or indirectly impacted by the events of the past year and, while it has presented many challenges, I could not be prouder of our Lakeland team for going above and beyond to support our customers and communities. Our team worked tirelessly to ensure the needs of our customers were addressed by increasing our lending, extending PPP loans, granting loan payment deferrals to borrowers, keeping our branches open and increasing donations to the communities we serve. The ongoing pandemic has impacted every sector of our society and dramatically changed the financial services industry. Yet, Lakeland maintained its position as one of New Jersey's leading banks and developed even closer relationships with our customers in the last year. We will continue to prudently navigate the current environment with the safety of our customers and associates at the forefront. Our financial performance in this environment was strong and directly related to our focus on addressing our customers' needs. In 2020, we experienced substantial balance sheet growth in both our loan and deposit portfolios. Our provision for projected credit losses increased significantly due to the pandemic; however, our loan charge-offs remained very low for the year. Due to our strong capital position, we will be recommencing our share repurchase plan in the first quarter of 2021." |
---|
Hot Stocks
|
Asur reports June traffic up 23.1% y/y, up 16.9% y/y from 2019 »
17:54 07/06/22 07/0617:54 07/06/2217:54
ASR
Asur
Grupo Aeroportuario del… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
Volaris reports June traffic results up 11% year-over-year »
17:34 07/06/22 07/0617:34 07/06/2217:34
VLRS
Volaris
Volaris reports June 2022… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
General Dynamics awarded $145.47M Defense Logistics Agency contract »
17:19 07/06/22 07/0617:19 07/06/2217:19
GD
General Dynamics
General Dynamics has been… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
DiaMedica Therapeutics down 38% to $1.25 after placing DM199 on clinical hold
17:13 07/06/22 07/0617:13 07/06/2217:13
DMAC
DiaMedica Therapeutics
ShowHide Related Items >><<
|
Hot Stocks
|
Shore Bancshares authorizes up to $5M stock buyback »
17:09 07/06/22 07/0617:09 07/06/2217:09
SHBI
Shore Bancshares
Shore Bancshares… Story temporarily locked. ShowHide Related Items >><<
|
Syndicate
|
Oil States files to sell 1.9M shares of common stock for holders
17:08 07/06/22 07/0617:08 07/06/2217:08
OIS
Oil States
ShowHide Related Items >><<
|
Hot Stocks
|
China Green removed from NYSE late filers list following quarterly report »
17:02 07/06/22 07/0617:02 07/06/2217:02
CGA
China Green
China Green announced… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
Blackstone announces $400M investment in Xpansiv »
17:01 07/06/22 07/0617:01 07/06/2217:01
BX
Blackstone
Blackstone… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
DiaMedica Therapeutics trading resumes
17:00 07/06/22 07/0617:00 07/06/2217:00
DMAC
DiaMedica Therapeutics
ShowHide Related Items >><<
|
Syndicate
|
Duckhorn Portfolio offers to sell 5M shares of common stock for holder »
16:56 07/06/22 07/0616:56 07/06/2216:56
NAPA
Duckhorn Portfolio
The Duckhorn Portfolio… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
Kilroy Realty announces new onsite solar projects in California »
16:54 07/06/22 07/0616:54 07/06/2216:54
KRC
Kilroy Realty
Kilroy Realty… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
DiaMedica Therapeutics to resume trading at 17:00ET
16:49 07/06/22 07/0616:49 07/06/2216:49
DMAC
DiaMedica Therapeutics
ShowHide Related Items >><<
|
Hot Stocks
|
Energy Services of America announces buyback for up to 1M shares of common stock »
16:46 07/06/22 07/0616:46 07/06/2216:46
ESOA
Energy Services of America
Energy Services of… Story temporarily locked. ShowHide Related Items >><<
|
Recommendations
|
Criteo price target lowered to $35 from $40 at Truist »
16:44 07/06/22 07/0616:44 07/06/2216:44
CRTO
Criteo
Truist analyst Matthew… Story temporarily locked. ShowHide Related Items >><<
|
General News
|
API crude inventories for week of July 1 »
16:40 07/06/22 07/0616:40 07/06/2216:40
USO
United States Oil Fund
API reports that crude… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
Crescent Point Energy raises quarterly dividend to 8c per share from 5c »
16:38 07/06/22 07/0616:38 07/06/2216:38
CPG
Crescent Point Energy
The Company's Board… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
Reservoir Media 'commends' U.S. Copyright Royalty Board phonorecords ruling »
16:37 07/06/22 07/0616:37 07/06/2216:37
RSVR
Reservoir Media
Reservoir Media, Inc.… Story temporarily locked. ShowHide Related Items >><<
|
Periodicals
|
Apple plans for larger Apple Watch geared towards extreme sports, Bloomberg says »
16:36 07/06/22 07/0616:36 07/06/2216:36
AAPL
Apple
Apple has plans for its… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
Veru jumps another 17% after Jefferies predicts FDA authorization »
16:36 07/06/22 07/0616:36 07/06/2216:36
VERU
Veru
Shares of Veru, which… Shares of Veru, which rallied 13% during the trading day to $13.02, jumped another 17% in after-hours trading to $15.39 after Jefferies predicted this morning's COVID-19 data would lead to an Emergency Use Authorization by the FDA in 30 days. Despite recent investor skepticism, the Phase 3 COVID-19 results for sabizabulin published this morning in the New England Journal of Medicine "addressed most concerns," Jefferies analyst Chris Howerton told investors in a research note. He reiterated a Buy rating on the shares with a $55 price target. ShowHide Related Items >><<
|
Syndicate
|
Duckhorn Portfolio files automatic mixed securities shelf
16:36 07/06/22 07/0616:36 07/06/2216:36
NAPA
Duckhorn Portfolio
ShowHide Related Items >><<
|
Hot Stocks
|
CytomX Therapeutics trading resumes
16:35 07/06/22 07/0616:35 07/06/2216:35
CTMX
CytomX Therapeutics
ShowHide Related Items >><<
|
Hot Stocks
|
DiaMedica says FDA puts clinical hold on Phase 2/3 ReMEDy2 trial »
16:34 07/06/22 07/0616:34 07/06/2216:34
DMAC
DiaMedica Therapeutics
DiaMedica Therapeutics… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
Altisource Asset Management appoints Jason Kopcak as CEO »
16:32 07/06/22 07/0616:32 07/06/2216:32
AAMC
Altisource Asset Management
Altisource Asset… Story temporarily locked. ShowHide Related Items >><<
|
Recommendations
|
Veru data likely portend FDA authorization in 30 days, says Jefferies »
16:31 07/06/22 07/0616:31 07/06/2216:31
VERU
Veru
Despite recent investor… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
First Bancshares receives regulatory approval for Beach Bancorp merger »
16:31 07/06/22 07/0616:31 07/06/2216:31
FBMS
First Bancshares
The First Bancshares… Story temporarily locked. ShowHide Related Items >><<
|